The company said it would likely move forward with the lower of two tested doses of the vaccine. It reported that eight study participants experienced adverse side effects after receiving a second vaccine dose during the trial. The company said none required medical intervention.
Maryland-based Novavax said its vaccine candidate, NVX-CoV2373, produced higher levels of the antibodies in healthy volunteers after two doses than those found in recovered COVID-19 patients, raising hopes for its eventual success. Effective vaccines and treatments are considered essential to halting a pandemic that has claimed more than 695,000 lives worldwide.
Spooky
Why does it sound so unreal, like I'm watching a bad movie...🤔🤔🤔
It stil has to go on trial fo another 3 mnths... Oh gosh how long shuld we wait or how pple shuld die bfre it's certain dat a 'Vaccine' is 💯 working
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Covid-19 Vaccine Produces Positive Results in First-Stage StudyNovavax said its experimental coronavirus vaccine induced promising immune responses and was generally well-tolerated in healthy adults in the first human study of the shot. Give everyone in Israel it since it's safe. The word 'generally' does not sound promising. 💪💪💪
Source: WSJ - 🏆 98. / 63 Read more »
Novavax's coronavirus vaccine generates promising immune response in early trial, data showsNovavax's potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday. Just make sure it's safe why then it dropped 25$ after hours?
Source: CNBC - 🏆 12. / 72 Read more »
As vaccines move into phase 3 trials, diversity must be at top of agendaEnsuring Black and ethnic minority participation in coronavirus vaccine trials is key if we want a truly effective coronavirus vaccine, according to experts. It's okay, race/ethnicity has nothing to do with biology I've been told. This sounds ridiculous and sensationalist. We're all human.. it's just a melanin thing.
Source: ABC - 🏆 471. / 51 Read more »
Novavax stock: Human results for coronavirus vaccine candidate - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. A friendly reminder: Phase I means absolutely nothing.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Progress slow on COVID-19 aid bill as negotiations continueProgress is coming slowly as lawmakers craft another major response to the coronavirus pandemic. Two of the most incompetent people in Washington, Schumer and Pelosi. They play all politics. Great, don’t worry about the eviction protections but get all military funding passed Only because the democrats want 3 trillion with 2/3s having nothing to do with Covid 19. If the democrats make it just a Covid 19 bill it will pass today.
Source: latimes - 🏆 11. / 82 Read more »
How Boom-Bust Vaccine Speculation Kneecapped the U.S. Coronavirus ResponseExecutives at Moderna, a leading contender for a COVID-19 vaccine, have pocketed millions, and the value of biotech companies has exploded. “People feel they can take risks,” says one expert—but for some it could all come crashing down. “Payoff” is the operative word, and the problem. Jonas Salk solved that problem with his polio vaccine. Making a huge profit was never the motivation or “payoff”. Helping his fellow human beings rid the world of polio. Rand Paul & Ayn Rand weep $
Source: VanityFair - 🏆 391. / 55 Read more »